Finance

Lists
Why is KYMR up २.८४%?
Dive Deeper
KYMR:NASDAQ
Kymera Therapeutics Inc
US$ ११२.४०
+२.८४%
(+३.१०) 1D
US$ ११२.४०
०.००% (०.००)
After hours
Closed: अक्टोबर ९, १६:००:०१ GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for KYMR...
Open
US$ १०९.५४
High
US$ ११५.८२
Low
US$ १०७.४६
Mkt. cap
९.३५ अरब
Avg. vol.
७.७९ लाख
Volume
१३.०५ लाख
52-wk high
US$ १३०.०५
52-wk low
US$ ५५.२६
EPS
-US$ ३.२४
Beta
१.९८
Shares outstanding
८.३२ करोड
No. of employees
२७३
Open
US$ १०९.५४
High
US$ ११५.८२
Low
US$ १०७.४६
Mkt. cap
९.३५ अरब
Avg. vol.
७.७९ लाख
Volume
१३.०५ लाख
52-wk high
US$ १३०.०५
52-wk low
US$ ५५.२६
EPS
-US$ ३.२४
Beta
१.९८
Shares outstanding
८.३२ करोड
No. of employees
२७३
News stories
From web sources and news partners
About Kymera Therapeutics Inc
CEO-
Employees२७३
Founded२०१५
HeadquartersWatertown, म्यासेचुसेट्स, संयुक्त राज्य अमेरिका
Sector-
Websitekymeratx.com
Analyst ratings
Based on 16 analysts giving stock ratings to KYMR in the past 3 months
Strong buy
Buy
14
Hold
2
Sell
0
12-month forecast
Based on 16 Wall Street analysts offering 12 month price targets for KYMR in the last 3 months.
Highest
Current US$ ११२.४०
US$ १८०.०० (+६०.१४%)
Average
US$ १४१.५० (+२५.८९%)
Lowest
US$ ११२.०० (-०.३६%)
Analyst
Recommendation
Action
Price target
Projected
Date
Thomas Deal
Raymond James
Buy
Initiated
US$ १४०.००
+२४.६%
10/08/2026
Unknown Analyst
Raymond James
Buy
Initiated
US$ १४०.००
+२४.६%
10/08/2026
Geoff Meacham
Citi
Buy
Maintained
US$ १५०.००
+३३.५%
10/05/2026
Brian Cheng
J.P. Morgan
Buy
Reiterated
US$ १४०.००
+२४.६%
09/28/2026
Biren Amin
Piper Sandler
Buy
Maintained
US$ १४०.००
+२४.६%
09/23/2026
Alex Thompson CFA
Stifel Nicolaus
Buy
Maintained
US$ १५२.००
+३५.२%
09/22/2026
Tazeen Ahmad
Bank of America Securities
Buy
Reiterated
US$ १४४.००
+२८.१%
09/14/2026
Andy Chen
Wolfe Research
Buy
Upgraded
US$ १८०.००
+६०.१%
09/10/2026
Brian Abrahams
RBC Capital
Hold
Maintained
US$ ११२.००
-०.४%
09/02/2026
Bradley Canino
Guggenheim
Buy
Reiterated
US$ १७०.००
+५१.२%
08/30/2026
Derek Archila
Wells Fargo
Buy
Reiterated
US$ १५१.००
+३४.३%
08/27/2026
Judah Frommer
Morgan Stanley
Buy
Reiterated
US$ १३५.००
+२०.१%
08/06/2026
Edward Nash
Canaccord Genuity
Buy
Reiterated
US$ १२९.००
+१४.८%
08/06/2026
David Dai
UBS
Buy
Maintained
US$ १२८.००
+१३.९%
08/05/2026
Andrew Fein
H.C. Wainwright
Buy
Maintained
US$ १३४.००
+१९.२%
08/06/2026
Eliana Merle
Barclays
Buy
Maintained
US$ १३९.००
+२३.७%
08/06/2026
David Hoang
Deutsche Bank
Hold
Initiated
US$ १२०.००
+६.८%
07/29/2026
Joseph Catanzaro
Mizuho Securities
Buy
Maintained
US$ १४०.००
+२४.६%
07/16/2026
Daniel Giraldo
Bank of America Securities
Buy
Reiterated
US$ १२५.००
+११.२%
06/29/2026
Srikripa Devarakonda
Truist Financial
Buy
Reiterated
US$ १३६.००
+२१%
06/29/2026
Mayank Mamtani
B. Riley Securities
Buy
Reiterated
US$ १५५.००
+३७.९%
06/29/2026
Unknown Analyst
B. Riley Securities
Buy
Maintained
US$ १५५.००
+३७.९%
06/26/2026
Unknown Analyst
Wells Fargo
Buy
Reiterated
US$ ११६.००
+३.२%
06/26/2026
Jeet Mukherjee
BTIG
Buy
Maintained
US$ १३४.००
+१९.२%
06/25/2026
Marc Frahm
TD Cowen
Buy
Maintained
-
-
05/05/2026
Kelly Shi
Jefferies
Buy
Initiated
US$ ११०.००
-२.१%
03/15/2026
Faisal Khurshid
Jefferies
Buy
Initiated
US$ ११०.००
-२.१%
03/15/2026
Sudan Loganathan
Stephens
Buy
Maintained
US$ १००.००
-११%
03/02/2026
Jeff Jones
Oppenheimer
Buy
Reiterated
US$ १२०.००
+६.८%
02/27/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
२७.६४ लाख
२८.७० लाख
३.४४ करोड
६.५० करोड
Cost of goods sold
७.४१ करोड
८.३८ करोड
९.८२ करोड
११.९५ करोड
Cost of revenue
७.४१ करोड
८.३८ करोड
९.८२ करोड
११.९५ करोड
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
१.७३ करोड
१.६९ करोड
२.०४ करोड
२.११ करोड
Operating expense
१.७३ करोड
१.६९ करोड
२.०४ करोड
२.११ करोड
Total operating expenses
९.१४ करोड
१०.०८ करोड
११.८५ करोड
१४.०६ करोड
Operating income
-८.८७ करोड
-९.७९ करोड
-८.४२ करोड
-७.५६ करोड
Other non operating income
-
-
५.०० हजार
-२५.०० हजार
EBT including unusual items
-८.२२ करोड
-८.७० करोड
-६.९२ करोड
-६.१२ करोड
EBT excluding unusual items
-७.८३ करोड
-८.७० करोड
-६.९२ करोड
-६.१२ करोड
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-८.२२ करोड
-८.७० करोड
-६.९२ करोड
-६.१२ करोड
Net profit margin
-२,९७३.०५%
-३,०३०.७०%
-२०१.४७%
-९४.१७%
Earnings per share
-०.९४
-०.९८
-०.७१
-०.६२
Interest and investment income
१.०४ करोड
१.१० करोड
१.५० करोड
१.४५ करोड
Interest expense
-९८.०० हजार
-९०.०० हजार
-६६.०० हजार
-५६.०० हजार
Net interest expenses
१.०३ करोड
१.०९ करोड
१.४९ करोड
१.४४ करोड
Depreciation and amortization charges
-
-
-
-
EBITDA
-८.५८ करोड
-९.७५ करोड
-८.२१ करोड
-७.४५ करोड
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google एपहरू